What some folks fail to understand is this thing is flirting with a valuation pointing to 0. The new product line doesn’t have a sign of traction and the old one is worth 0 based on current cost structure. A RS would boost the stock price into a range that certainly would be attractive to short sellers, but not if the market cap looks appropriate. And the market cap will be dependent on performance. So if Q4 and Q1 are poor then yes, it will be going down and down.
News 
Market Data 
Discover 
